These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11071627

  • 1. Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.
    Reich S, Bührer C, Henze G, Ohlendorf D, Mesche M, Sinha P, Kage A, Müller C, Vetter B, Kulozik AE.
    Blood; 2000 Nov 15; 96(10):3357-63. PubMed ID: 11071627
    [Abstract] [Full Text] [Related]

  • 2. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.
    Collins AF, Pearson HA, Giardina P, McDonagh KT, Brusilow SW, Dover GJ.
    Blood; 1995 Jan 01; 85(1):43-9. PubMed ID: 7528572
    [Abstract] [Full Text] [Related]

  • 3. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.
    Acta Haematol; 2004 Jan 01; 111(4):189-95. PubMed ID: 15153710
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A.
    Ann Hematol; 2014 Dec 01; 93(12):2045-50. PubMed ID: 25062719
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of thalidomide for various genotypes of beta thalassemia.
    Yang WJ, Kang QP, Zhou Q, Lin T, Gong XM, Huang CJ, Dou M, Lin Y.
    BMC Med Genomics; 2024 Jul 18; 17(1):191. PubMed ID: 39026312
    [Abstract] [Full Text] [Related]

  • 8. Butyrate trials.
    Cappellini MD, Graziadei G, Ciceri L, Comino A, Bianchi P, Pomati M, Fiorelli G.
    Ann N Y Acad Sci; 1998 Jun 30; 850():110-9. PubMed ID: 9668533
    [Abstract] [Full Text] [Related]

  • 9. Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients.
    Bourantas KL, Georgiou I, Seferiadis K.
    Acta Haematol; 1994 Jun 30; 92(2):79-82. PubMed ID: 7529455
    [Abstract] [Full Text] [Related]

  • 10. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.
    J Matern Fetal Med; 1999 Jun 30; 8(1):1-7. PubMed ID: 10052837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia.
    Thein SL.
    Blood Rev; 2012 Apr 30; 26 Suppl 1():S35-9. PubMed ID: 22631042
    [Abstract] [Full Text] [Related]

  • 14. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A, Levin C, Dgany O, Kransnov T, Elhasid R, Zalman L, Palmor H, Tamary H.
    Am J Hematol; 2008 May 30; 83(5):366-70. PubMed ID: 18181203
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia.
    Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M.
    Blood; 2003 Aug 15; 102(4):1529-30. PubMed ID: 12702505
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS, Adly AA, Ismail EA, Elhenawy YI, Elghamry IR.
    Eur J Haematol; 2013 Dec 15; 91(6):522-33. PubMed ID: 23927461
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
    Ehsani MA, Hedayati-Asl AA, Bagheri A, Zeinali S, Rashidi A.
    Pediatr Hematol Oncol; 2009 Nov 15; 26(8):560-5. PubMed ID: 19954365
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.